dexamethasone implant for diabetic macular oedema

Last edited 09/2022 and last reviewed 09/2022

Dexamethasone Implant for Diabetic Macular Oedema

Study evidence found that the dexamethasone implant generally maintained vision at 12 months in eyes with diabetic macular oedema in routine clinical practice (1)

  • treatment with the steroid implant was relatively safe
  • a few eyes on dexamethasone implant treatment had IOP (intraocular pressure) elevation that required treatment and a few others had cataract surgery during the 12 months

NICE state that:

  • dexamethasone intravitreal implant is recommended as an option for treating visual impairment caused by diabetic macular oedema in adults only if their condition has not responded well enough to, or if they cannot have non-corticosteroid therapy

Reference:

  1. Bhandari S et al. Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry. Ophthalmol Ther. 2022 Apr;11(2):797-810.
  2. NICE (September 2022). Dexamethasone intravitreal implant for treating diabetic macular oedema

Related pages:

diabetic macular oedema